Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00554177 · ClinicalTrials.gov registry record · Phase 1
A Clinical Trial for Post Traumatic Stress Disorder
A Phase 1 study of Posttraumatic Stress Disorder (PTSD), sponsored by Antonia New.
- Completed
- Registry status
- Phase 1
- Development phase
- 5
- Enrollment target
- 1
- Study location
NCT00554177: Completed Phase 1 study of Posttraumatic Stress Disorder (PTSD), sponsored by Antonia New.
NCT00554177 is a Phase 1 study of Posttraumatic Stress Disorder (PTSD) that has completed, run by Antonia New. The registered enrollment target is 5 participants, below the 112-participant average among 31 other Posttraumatic Stress Disorder (PTSD) trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00554177, a Phase 1 study of Posttraumatic Stress Disorder (PTSD), has completed, sponsored by Antonia New.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 5 participants
- Enrollment target
- 1
- Study location
Study Summary
he purpose of this study is to test whether a medication, called mifepristone (commonly known as the ³Morning-After-Pill²), can help to prevent emotional problems after someone has survived a traumatic experience. We are studying this medication for the treatment of Post-traumatic Stress disorder (PTSD.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Medicane (mifepristone)
Study Locations (1)
New York
- Mount Sinai School of Medicine - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2007-09 |
| Est. Completion | 2008-12 |
| Phase | Phase 1 |
What the finished NCT00554177 record still lists
NCT00554177 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 112-participant average among 31 other Posttraumatic Stress Disorder (PTSD) trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Posttraumatic Stress Disorder (PTSD) appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT00554177 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT00554177 about?
NCT00554177 is a clinical study titled "A Clinical Trial for Post Traumatic Stress Disorder". he purpose of this study is to test whether a medication, called mifepristone (commonly known as the ³Morning-After-Pill²), can help to prevent emotional problems after someone has survived a traumatic experience. We are studying this medication for the treatment of Post-traumatic Stress disorder (P...
What is the current status of trial NCT00554177?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 5 participants. The study started on 2007-09. Estimated completion is 2008-12.
What conditions does trial NCT00554177 study?
This clinical trial studies the following conditions: Posttraumatic Stress Disorder (PTSD).
What interventions are being tested in trial NCT00554177?
The interventions under investigation include: Placebo (DRUG), Medicane (mifepristone) (DRUG).
Who is sponsoring clinical trial NCT00554177?
This trial is sponsored by Antonia New, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00554177 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Posttraumatic Stress Disorder (PTSD)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00554177's enrollment target sits among peer trials
5 32nd of 31 the lowest of 31 other Posttraumatic Stress Disorder (PTSD) trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Posttraumatic Stress Disorder (PTSD) trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Inflammatory Challenge and Fear
RECRUITING · Phase 1
-
Effect of Sublingual Formulation of Dexmedetomidine Hydrochloride (HCl) (BXCL501) - Outpatient Study
RECRUITING · Phase 1
-
Acupuncture for the Treatment of Posttraumatic Stress Among Military Personnel
COMPLETED · Phase 1
-
Treatment for PTSD and Tinnitus
RECRUITING · NA
-
A Neurosensory Account of Anxiety and Stress (Study 2)
RECRUITING · NA
-
Augmenting Massed Cognitive Processing Therapy (CPT) to Prevent Suicide Risk Among Patients With PTSD
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia